Joshua D. Mitchell - Publications, H-index & Citations

Joshua D. Mitchell

cardio-oncology center of excellence

28H指数

170论文数

4.9K被引数

收录论文 67

发表时间

Patient perspectives on cardioprotective medication during breast cancer treatment 乳腺癌治疗期间患者对心脏保护药物的看法

Cardio-Oncology

IF3.2

2026-09-29

OAAI

Lauren Houston; Nusayba A. Bagegni; Mei Ling Yap; Elgene Lim; Bruce Neal; Anita Deswal; Joshua D. Mitchell; Clare Arnott; Sang Gune K. Yoo

CART-8 and cardiovascular risk stratification: informing, not restricting, CAR-T therapy CART-8与心血管风险评估：提供信息而非限制CAR-T疗法

European Heart Journal

IF35.6

2026-09-10

PREAI

Raja Zaghlol; Elena Deych; Joshua D Mitchell

A Phase 3 Open Label Multicenter Study of I124 Evuzamitide as an Imaging Agent for the Diagnosis of Cardiac Amyloidosis Using Positron Emission Tomography Computed Tomography PETCT I124埃夫扎米替定作为正电子发射断层扫描计算机断层扫描（PETCT）诊断心脏淀粉样变性的开放标签多中心III期研究

Journal of Nuclear Cardiology

IF2.7

2026-09-09

PREAI

Sharmila Dorbala; Mathew S. Maurer; Sarah AM. Cuddy; Michel G. Khouri; Joshua D. Mitchell; Brett W. Sperry; Mazen Hanna; Omar Abou Ezzeddine; Saurabh Malhotra; Jonathan S. Wall; Spencer Guthrie; Brian Mangal; Marcelo F. Di Carli; Frederick L. Ruberg; Vasken Dilsizian; Angela Dispenzieri; James E. Udelson; Ravi K. Narra; Ahmad Masri

Heart Substructure Radiation Dose and Cardiac Outcomes: Contemporary Evidence and Actionable Opportunities 心脏亚结构辐射剂量与心脏结局：当代证据和可操作机会

JACC: CardioOncology

IF12.8

2026-06-16

OAAI

Katelyn M. Atkins; Gerard Walls; Andriana P. Nikolova; Joel Ferrall; Maria Oorloff; Jakub Bychowski; Kollin Kolb; Anja Karlstaedt; Joshua D. Mitchell; Raymond H. Mak; Carmen Bergom

Design and Rationale of the REVEAL PET Study: A Study of 124I-evuzamitide to Diagnose Cardiac Amyloidosis REVEAL PET研究的方案设计与依据：一项关于使用124I-evuzamitide诊断心肌淀粉样变性的研究

Journal of Nuclear Cardiology

IF2.7

2026-06-15

PREAI

Sharmila Dorbala; Mathew S. Maurer; Sarah A.M. Cuddy; Benjamin D. Auer; Marie Foley Kijewski; Olivier F. Clerc; Michel G. Khouri; Joshua D. Mitchell; Brett W. Sperry; Mazen Hanna; Omar F. AbouEzzeddine; Saurabh Malhotra; Jonathan S. Wall; Spencer Guthrie; Marcelo F. Di Carli; Frederick L. Ruberg; Vasken Dilsizian; Angela Dispenzieri; James E. Udelson; Ravi K. Narra

Chimeric antigen receptor T-cell therapy and cardiovascular outcomes in US Medicare beneficiaries 嵌合抗原受体T细胞疗法与美国医疗保险受益者的心血管结局

European Heart Journal

IF35.6

2026-05-26

PREAI

Raja Zaghlol; Elena Deych; Daniel A Ladin; David A Russler-Germain; Walter Schiffer; Nischit Baral; R J Waken; Bonnie Ky; Karen E Joynt Maddox; Joshua D Mitchell

Correction: CPX-351 vs. conventional chemotherapy cardiotoxicity in high-risk AML: a post hoc phase III trial analysis 更正：CPX-351与常规化疗的心脏毒性比较：高风险AML的III期试验事后分析

Cardio-Oncology

IF3.2

2026-05-23

OAAI

Joshua D. Mitchell; Michael Pfeiffer; John Boehmer; John Gorcsan; Shunsuke Eguchi; Yoshiyuki Orihara; Nalina Dronamraju; Sonja Dhani; Stefan Faderl; Tara L. Lin; Geoffrey L. Uy; Jeffrey E. Lancet; Jorge E. Cortes

Acoramidis, Serum Transthyretin, and Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM Trial 阿科拉米定、血清甲状腺素结合球蛋白和转甲状腺素蛋白淀粉样变性心肌病的心血管结局：ATTRibute-CM试验的启示

Journal of Cardiac Failure

IF8.2

2026-05-12

OAAI

AMRUT V. AMBARDEKAR; NITASHA SARSWAT; RICHARD WRIGHT; JOHN BERK; MARGOT K. DAVIS; PABLO GARCIA-PAVIA; JULIAN D. GILLMORE; JUSTIN L. GRODIN; JOSHUA D. MITCHELL; DEIRDRE MOONEY; JOSE NATIVI-NICOLAU; STEEN H. POULSEN; FREDERICK L. RUBERG; CHRIS CHEN; ALAN JI; SURESH SIDDHANTI; JEAN-FRANÇOIS TAMBY; ADAM CASTAÑO; LEONID KATZ; UMA SINHA

Clinical Relevance of Coronary Artery Calcifications in Radiation Oncology 冠状动脉钙化在放射肿瘤学中的临床相关性

Current Breast Cancer Reports

IF0.9

2026-05-01

PREAI

Chen, Kevin; Bychowski, Jakub; Manova, Angelena; Thomas, Maria; Yang, Joanna C.; Samson, Pamela; Hugo, Geoffrey D.; Atkins, Katelyn M.; Mitchell, Joshua D.; Bergom, Carmen

CPX-351 vs. conventional chemotherapy cardiotoxicity in high-risk AML: a post hoc phase III trial analysis CPX-351与常规化疗的心脏毒性比较：高风险AML的III期试验事后分析

Cardio-Oncology

IF3.2

2025-11-25

OAAI

Cardiac substructure radiotherapy dose and changes in physical activity and quality of life after chemoradiotherapy for NSCLC: a secondary analysis of the CLARITY prospective study cardiac substructure dose and PROs in NSCLC 非小细胞肺癌(NSCLC)化疗放疗后的心脏亚结构放射剂量以及身体活动与生活质量的变化：CLARITY前瞻性研究心脏亚结构剂量和患者报告结果(PRO)的二次分析

Clinical and Translational Radiation Oncology

IF2.7

2025-11-12

OAAI

Nikhil Yegya-Raman; Kyunga Ko; Ivy S. Han; Joshua D. Mitchell; Wei Zou; Nitin Ohri; Salma K. Jabbour; Raymond H. Mak; Clifford Robinson; William P. Levin; Leanne Barrett; Congying Xia; Eva Berlin; Paco Bravo; Marcelo Di Carli; Roger Cohen; Sandra Hutton; Jonathan Keltz; Jessica Wang; Omotayo Fasan; Suneel N. Nagda; Angie Seo; Amanda M. Smith; Lova Sun; Michael Soike; Adam J. Kole; Gerard Walls; Steven J. Feigenberg; Bonnie Ky

Prevalence and prognostic value of elevated computed tomography coronary artery calcium scores in Indigenous peoples globally: A systematic review

INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING

IF1.5

2025-11-01

PREAI

Cheung, Kevin; Pant, Anushriya; Dang, Denee; Ridsdill-Kenny, Elise; Marschner, Simone; Kuhn, Lisa; Wing-Lun, Edwina; Mitchell, Joshua; Bittencourt, Marcio; Zaman, Sarah

Cardiovascular and Oncologic Considerations in Adult Hodgkin Lymphoma 成人霍奇金淋巴瘤的心血管和肿瘤学考量

JACC: CardioOncology

IF12.8

2025-09-15

OAAI

Hari S. Raman; Joshua Mitchell; Anju Nohria; Jenica N. Upshaw; Ann S. LaCasce

Particle transport modelling for D/T ratio control experiments in JET JET中D/T比例控制实验的粒子输运建模

Nuclear Fusion

IF4

2025-09-12

OAAI

K.K. Kirov; M. Lennholm; L. Piron; D. Valcarcel; P. Almond; M. Baruzzo; M. van Berkel; T. Bosman; L. Ceelen; P. Fox; L. Garzotti; Z. Ghani; B. Kool; C. Lowry; J. Mitchell; B. Sieglin; H. Sun; JET contributors; the EUROfusion Tokamak Exploitation Team

Cardiac Biomarkers as an Early Warning System in Transthyretin Cardiac Amyloidosis 转甲状腺素蛋白心脏淀粉样变性中，心脏生物标志物作为早期预警系统

Journal of the American College of Cardiology

IF22.3

2025-08-04

PREAI

Joshua D. Mitchell; Nicole Nakamatsu; Richard K. Cheng

ASO Author Reflections: Plasma Ceramide Levels Aid in Prognosis in Pancreatic Ductal Adenocarcinoma

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2025-04-01

PREAI

Mitchell, Joshua D.; Peterson, Linda R.

Severe Aortic Stenosis and Chronic Myeloid Leukemia Considerations for Valve Management 严重主动脉瓣狭窄和慢性粒细胞白血病患者的瓣膜管理考量

JACC: CARDIOONCOLOGY

IF12.8

2025-02-01

OAAI

Cunningham, Rebecca; Yoo, Sang Gune K.; Brescia, Alexander A.; Oetjen, Karolyn A.; Pusic, Iskra; Mitchell, Joshua D.

Cardiotoxicity following thoracic radiotherapy for lung cancer (Jan, 10.1038/s41416-024-02888-0, 2025)

BRITISH JOURNAL OF CANCER

IF6.8

2025-01-07

OAAI

Walls, Gerard M.; Bergom, Carmen; Mitchell, Joshua D.; Rentschler, Stacey L.; Hugo, Geoffrey D.; Samson, Pamela P.; Robinson, Clifford G.

Radiation Oncology Opinions and Practice on Cardiotoxicity in Lung Cancer: A Cross-sectional Study by the International Cardio-oncology Society

CLINICAL ONCOLOGY

IF3

2024-12-01

OAAI

Walls, G. M.; Mitchell, J. D.; Lyon, A. R.; Harbinson, M.; Hanna, G. G.

Coronary artery calcium on lung cancer radiation planning CT aids cardiovascular risk assessment

CARDIO-ONCOLOGY

IF3.2

2024-11-12

OAAI

Lui, Matthew; Kim, Noah; Zaghlol, Raja; Joolharzadeh, Pouya; Deych, Elena; Robinson, Clifford; Badiyan, Shahed; Woodard, Pamela K.; Mitchell, Joshua D.

研究方向